MLCK, a downstream kinase of PKC, is reported to not contribute to TJ disruption during RVA infection, as treatment of Caco-2 cells with the MLCK inhibitor ML-9 did not reduce time of onset or rate of loss of TER60. Here, PRRT2 is linked to infection.